miR-142-3p upregulation can decrease autophagy by targeting autophagy-related 5 (ATG5) and autophagy-related 16-like 1 (ATG16L1), thereby increasing the sensitivity of HCC cells to sorafenib and enhancing the apoptosis induced by sorafenib. This evidence concerns the gene ATG16L1 and hepatocellular carcinoma.